Alexandra E. Shields, Director of the Harvard/MGH Center on Genomics, Vulnerable Populations, and Health Disparities
Anne L van de Ven, Assistant Director, CaNCURE
Terrence Norchi, MD, President and CEO of Arch Therapeutics
Andy Watson, Vice President Corporate Development, Cell Signaling Technology (CST)